Webinars

To foster the continued advancement and understanding of radiosurgery, regardless of SRS technology or platform, ZAP Surgical routinely hosts educational symposia and webinars.

Tuesday, September 5 /

11:00 AM ET

Dedicated vs multi-purpose SRS delivery platforms: is good enough, good enough?

Too often we hear legacy SRS technologies are good enough. Are they – particularly when treating the brain? Most technologies can shine when focused on a single point of optimization. But what if you analyze multiple criteria together? Join Ian Paddick, MSc on Tue, Sep 5 and find out for yourself. Sponsored by ZAP Surgical, there is no fee to attend.

Presented By

Can’t attend the live discussion?
Register and we will send you a recording after the event.

Stereotactic Radiosurgery

RSS Webinar: Vault-Free, Cobalt-Free SRS – ZAP-X Introduction & Case Review from Neurosurgery One

David VanSickle, MD, PhD, FAANS

Justin Keener, MS, DABR

RSS Webinar: Vault-Free, Cobalt-Free Radiosurgery – ZAP-X Clinical Experience at SNRC, Zurich

Andreas Mack, PhD

Dedicated vs Multi-Purpose SRS Systems — Benchmarking Comparisons in the Literature

Ian Paddick, MSc

SRS for Brain Mets – How Big is Too Big? How Many is Too Many?

Scott Soltys, MD

Aizik Wolf, MD

New Thinking and Controversies in Radiosurgery Debate: SRS vs. Surgery for Vestibular Schwannoma

Alexander Muacevic, MD, Professor

Michael W. McDermott, MD, FAANS

SRS for Vestibular Schwannomas: Clinical Advantage to Use Pathological Micro-anatomy Dose Planning

Motohiro Hayashi, MD, DMSc

A Phase III Trial of SRS vs. HA-WBRT for Multiple (5-15) Metastases

David Roberge, MD

Radiosurgery Versus Microsurgery for Cavernous Sinus Meningiomas: What Does the Literature Say?

Michael McDermott, MD, FAANS

Radiosurgery for Acoustic Neuromas

Isaac Yang, MD

Current Role and Limitations of Radiosurgery in the Management of Glomus Tumors (Paragangliomas)

Dr. Manjul Tripathi

Stereotactic Radiation Therapy of Choroidal Melanoma

Jun Itami, MD, PhD

Lifetime Risk from Extracranial Doses Received During SRS

Ian Paddick, MSc

Theoretical Application of SRS for Cerebral Aneurysms: Early Experience with Animal Models

James McInerney, MD, FAANS, FACS

The Next Great Radiosurgical Frontier: Neuromodulation

John Adler, MD

Frameless Radiosurgery for Trigeminal Neuralgia: Dispelling the Controversy

Alfredo Conti, MD, PhD, FENS

Economics of SRS as an Alternative to Open Surgery

Doug Kondziolka, MD

Linda Winger, MSc, FACHE

Emerging Trends in Brain Tumor Therapy

Minesh Mehta, MD

Radiosurgery for Arteriovenous Malformations

Constantin Tuleasca, MD-PhD

Clinical Experience and Best Practices for Functional SRS

Antonio De Salles, MD

NEUROMODULATION

THE FUTURE OF RADIOSURGERY?

A Scientific Research Summit

In March 2022, experts from around the world gathered in Miami, Florida to join Dr. Michael McDermott of Miami Neuroscience Institute, Dr. John Adler of Stanford University, and ZAP Surgical to discuss the next potential frontier in stereotactic radiosurgery: Neuromodulation.

Neuromodulation is not a cleared indication for stereotactic radiosurgery.